Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Venous Thromboembolism 2Prostatic Neoplasms 2Neoplasms 2Endometrial Neoplasms 2Cardiovascular Diseases 2Venous Thrombosis 1Stroke 1Rectal Neoplasms 1Pulmonary Embolism 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neoplasm Metastasis 1Ischemic Attack, Transient 1Hypoalphalipoproteinemias 1Healthy Volunteers 1Endometrial Hyperplasia 1Cardiotoxicity 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Atherosclerosis 1

Interventions

Acupuncture Therapy 10Exercise 6Cryotherapy 6Paclitaxel 5Glutamine 4Surveys and Questionnaires 3Duloxetine Hydrochloride 3Dexamethasone 3Bortezomib 3Acetylcysteine 3Thioctic Acid 2Tablets 2Sodium Chloride 2Saline Solution 2Physical Therapy Modalities 2Low-Level Light Therapy 2Fish Oils 2Fatty Acids, Omega-3 2ziconotide 1pembrolizumab 1nicotinamide-beta-riboside 1glutamic acid diethyl ester 1enfortumab vedotin 1Yoga 1XELOX 1Vitamin D 1Vitamin B Complex 1Vitamin B 6 1Vitamin B 12 1Ultrasonic Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Peripheral Nervous System Diseases × Rosuvastatin Calcium × Clear all
NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Tanta University

Phase 2/3 Not yet recruiting
46 enrolled

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡